EnBio Holdings, Inc (6092.T)

JPY 580.0

(-1.02%)

Annual Income Statements

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Revenue 9.57 Billion 8.12 Billion 8.98 Billion 6.84 Billion 7.4 Billion
Cost of Revenue 7.09 Billion 5.35 Billion 6.56 Billion 4.95 Billion 5.32 Billion
Gross Profit 2.48 Billion 2.76 Billion 2.42 Billion 1.88 Billion 2.08 Billion
Operating Expenses 1.66 Billion 1.4 Billion 1.19 Billion 1.27 Billion 1.12 Billion
Selling, General and Administrative Expenses 1.66 Billion 1.4 Billion 1.18 Billion 1.16 Billion 1.26 Billion
Research and Development Expenses - 6 Million 6 Million 8 Million 25 Million
Other Expenses 1.66 Billion 2.29 Million -30.6 Million -11.87 Million -151.9 Million
Cost and Expenses 8.76 Billion 6.76 Billion 7.75 Billion 6.22 Billion 6.44 Billion
Operating Income 815.15 Million 1.35 Billion 1.22 Billion 617.9 Million 674 Million
Interest Expense 114.66 Million 124.89 Million 123.88 Million 125.51 Million 130.16 Million
Income Tax Expense 326.25 Million 437.61 Million 392.4 Million 157.13 Million 301 Million
Earnings before Tax 1.06 Billion 1.23 Billion 1.09 Billion 488.31 Million 833 Million
Net Income 708.76 Million 812.05 Million 654.05 Million 304.06 Million 555 Million
Earnings Per Share Basic 88.75 122.27 98.52 46.22 84.68
Earnings Per Share Diluted 88.75 122.27 98.47 45.76 83.58
Weighted Average Shares Outstanding 7.97 Million 6.64 Million 6.63 Million 6.57 Million 6.55 Million
Weighted Average Shares Outstanding (Diluted) 7.97 Million 6.64 Million 6.64 Million 6.64 Million 6.64 Million
Gross Margin 0.26 0.34 0.27 0.28 0.28
EBIT Margin 0.17 0.23 0.18 0.15 0.15
Profit Margin 0.07 0.10 0.07 0.04 0.07
EBITDA 1.61 Billion 1.75 Billion 1.56 Billion 981 Million 1.1 Billion
Earnings Before Tax Margin 0.09 0.17 0.14 0.09 0.09

Income Statement Charts